Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management

Giorgio Grani, Livia Lamartina, Cosimo Durante, Sebastiano Filetti, David S Cooper
  • The Lancet Diabetes & Endocrinology, June 2018, Elsevier
  • DOI: 10.1016/s2213-8587(17)30325-x

The distinctive traits of Follicular thyroid cancer and Hürthle cell cancer

What is it about?

Follicular thyroid cancer is the second most common thyroid cancer type and has certain unique aspects of presentation and prognosis.

Why is it important?

This is a comprehensive literature review on the topic, encompassing peculiar aspects of diagnosis, prognosis, and treatment of follicular thyroid cancer and Hürthle cell cancer.

Perspectives

Dr. Giorgio Grani
Sapienza University of Rome

No specific recommendations exist for follicular thyroid cancer and Hürthle cell carcinoma in evidence-based guidelines. Efforts should be made to stimulate additional research in this field.

Sebastiano Filetti
Universita degli Studi di Roma La Sapienza

No specific recommendations exist for follicular thyroid cancer and Hürthle cell carcinoma in evidence-based guidelines. Efforts should be made to stimulate additional research in this field.

Read Publication

http://dx.doi.org/10.1016/s2213-8587(17)30325-x

The following have contributed to this page: Dr. Giorgio Grani and Sebastiano Filetti